Adicet Bio Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +46.0% | -168.9% | – | -5.5% | +78.8% | +7.4% | -1.6% | -66.7% | -238.5% | – | – | – | – | – | – | – | – | |
| – | -21.5% | +49.8% | +96.8% | +26.2% | +0.0% | +0.0% | +16.5% | +46.4% | -100.0% | +24,340.0% | +1.3% | -1.0% | +25.4% | +67.4% | +136.8% | +6.1% | -64.6% | |
| – | +21.4% | -33.1% | -18.1% | +36.8% | +53.1% | +0.0% | +76.5% | +43.8% | -89.6% | +427.4% | -52.6% | +347.9% | +137.7% | +36.9% | +18.3% | +9.7% | -35.8% | |
| – | +19.1% | -102.8% | – | – | – | +247.2% | +192.5% | -6.7% | -84.5% | -288.7% | – | -4,066.0% | – | – | -90.8% | -2,292.5% | – | |
| – | -53.5% | +611.0% | +37.0% | -79.8% | -6.9% | +0.0% | +12.0% | -46.1% | -92.9% | +1,890.9% | +22.1% | -7.5% | +1,217.8% | +28.6% | -73.4% | -75.0% | +55.5% | |
| – | -389.4% | +50.4% | +1,032.8% | -97.4% | -40.5% | +165.2% | +2,967.6% | -89.6% | -99.5% | +36,395.5% | +198.5% | – | -102.4% | +500.2% | -73.4% | +2,571.2% | – | |
| – | – | +2.4% | +2.7% | +2.4% | +12.8% | +0.0% | +13.1% | +2.3% | +1.7% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +33.7% | +29.1% | -20.7% | +96.4% | -16.7% | – | – | – | – | – | -95.4% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -29.3% | -42.7% | – | -130.6% | -6.5% | +0.0% | – | -111.7% | – | -83.0% | +596.6% | -99.6% | +79,994.1% | -82.9% | -99.4% | +47,064.0% | -32.4% | |
| – | -20.8% | -339.3% | – | – | – | +0.0% | +15.5% | -191.8% | – | -176.1% | – | +6,434.3% | +155.3% | -110.6% | – | – | – | |
| – | +54.4% | -188.6% | – | +41.3% | +86.6% | +7.7% | -2.2% | -67.7% | -250.1% | – | – | – | – | – | – | – | – |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.